DOI:
10.1055/s-00050098
Journal of Coloproctology
LinksClose Window
References
Aoyagi Y, Iinuma H, Horiuchi A, Shimada R, Watanabe T.
Association of plasma VEGF-A, soluble VEGFR-1 and VEGFR-2 levels and clinical response and survival in advanced colorectal cancer patients receiving bevacizumab with modified FOLFOX6.
Oncol Lett 2010;
1 (02) 253-259
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.